ORGN Strangle Strategy
ORGN (Origin Materials, Inc.), in the Basic Materials sector, (Chemicals industry), listed on NASDAQ.
Micromidas, Inc., doing business as Origin Materials, produces and commercializes plant-based PET plastic. It develops a platform for turning the carbon found in biomass into useful materials, while capturing carbon in the process. The company serves tire filler, carbon black, agriculture, and activated carbon markets. Micromidas, Inc. has a strategic alliance with Palantir Technologies Inc. The company was incorporated in 2008 and is based in West Sacramento, California with a facility in Sarnia, Canada.
ORGN (Origin Materials, Inc.) trades in the Basic Materials sector, specifically Chemicals, with a market capitalization of approximately $6.9M, a beta of 1.27 versus the broader market, a 52-week range of 1.225-28.5, average daily share volume of 152K, a public-listing history dating back to 2020, approximately 109 full-time employees. These structural characteristics shape how ORGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.27 places ORGN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on ORGN?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current ORGN snapshot
As of May 15, 2026, spot at $1.27, ATM IV 114.10%, IV rank 20.76%, expected move 32.71%. The strangle on ORGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 98-day expiry.
Why this strangle structure on ORGN specifically: ORGN IV at 114.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a ORGN strangle, with a market-implied 1-standard-deviation move of approximately 32.71% (roughly $0.42 on the underlying). The 98-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORGN should anchor to the underlying notional of $1.27 per share and to the trader's directional view on ORGN stock.
ORGN strangle setup
The ORGN strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORGN near $1.27, the first option leg uses a $1.33 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORGN chain at a 98-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.33 | N/A |
| Buy 1 | Put | $1.21 | N/A |
ORGN strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
ORGN strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on ORGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on ORGN
Strangles on ORGN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ORGN chain.
ORGN thesis for this strangle
The market-implied 1-standard-deviation range for ORGN extends from approximately $0.85 on the downside to $1.69 on the upside. A ORGN long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current ORGN IV rank near 20.76% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ORGN at 114.10%. As a Basic Materials name, ORGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORGN-specific events.
ORGN strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORGN positions also carry Basic Materials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORGN alongside the broader basket even when ORGN-specific fundamentals are unchanged. Always rebuild the position from current ORGN chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on ORGN?
- A strangle on ORGN is the strangle strategy applied to ORGN (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With ORGN stock trading near $1.27, the strikes shown on this page are snapped to the nearest listed ORGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ORGN strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the ORGN strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 114.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ORGN strangle?
- The breakeven for the ORGN strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ORGN market-implied 1-standard-deviation expected move is approximately 32.71%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on ORGN?
- Strangles on ORGN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ORGN chain.
- How does current ORGN implied volatility affect this strangle?
- ORGN ATM IV is at 114.10% with IV rank near 20.76%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.